HERE Technologies and Radaro Partner to Deliver Next-Gen Route Optimisation and Tour Planning Solution for Enterprise-Grade Logistics
Radaro leverages HERE’s comprehensive suite of location services to enhance delivery lifecycle…
India’s Top YouTube Creator Dhruv Rathee Teams Up with YC-Backed TagMango Founders to Launch AI Fiesta; Hits $3M ARR in Just 36 Hours
One subscription. Six top AI models. Built in India for the world…
337,000 Orion Corporation A shares converted into B shares
August 20, 2025 02:00 ET | Source: Orion Oyj ORION CORPORATION STOCK…
CARD91 Launches AI-Powered UPI Credit Scoring Engine to Enable Smarter Lending and Drive Financial Inclusion
BANGALORE, India, Aug. 7, 2025 /PRNewswire/ -- CARD91, a leading payments infrastructure…
Sandoz delivers strong H1 2025 results, with accelerated sales growth in the second quarter
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules…
![Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]](https://i0.wp.com/ml-eu.globenewswire.com/media/NjEzMmQ4NzAtZTBkMS00ZDhhLTkyYjgtOGM3YzY1ZWM5M2U5LTEwMTQyODItMjAyNS0wNi0wMi1lbg==/tiny/Sandoz-International-GmbH.png?w=420&resize=420,280&ssl=1 "Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]")
Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]
Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA…